Research Article
Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides
Table 3
The mean value of all cell surface antigens between groups.
| | CD molecule | Mycosis fungoides | Parapsoriasis | Benign erythroderma | | | : 121 | : 17 | : 11 | |
| | CD3+ | | | | 0.917 | | Mean ± SD | 73.66 ± 9.62 | 71.12 ± 3.33 | 62.97 ± 23.26 | | | Median; min.–max. | 73.60; 48.70–98.70 | 70.90; 67.70–74.70 | 58.70; 43.60–90.90 | | | CD4+ | | | | 0.754 | | Mean ± SD | 47.54 ± 13.26 | 43.0 ± 8.81 | 39.62 ± 27.09 | | | Median; min.–max. | 45.3 ± 15.30–97.50 | 48.70; 31.20–50.40 | 32.05; 15,80–78.60 | | | CD8+ | | | | 0.954 | | Mean ± SD | 23.49 ± 10.62 | 25.96 ± 4.86 | 20.95 ± 9.86 | | | Median; min.–max. | 22.0; 0.50–73.30 | 24.9; 21.40–32.60 | 20.3; 10.60–32.60 | | | CD4+/CD8+ | | | | 0.836 | | Mean ± SD | 5.61 ± 18.69 | 1.74 ± 0.6 | 2.40 ± 2.09 | | | Median; min.–max. | 2.0; 0.2–183.2 | 2.0; 0.90–2.30 | 1.95; 0.60–5.10 | | | TCRαβ+ | | | | 0.944 | | Mean ± SD | 68.96 ± 9.66 | 67.88 ± 4.0 | 58.80 ± 20.71 | | | Median; min.–max. | 69.10; 45.80–98.0 | 69.60; 63.10–72.50 | 53.35; 42.0–86.50 | | | TCRγδ+ | | | | 0.056 | | Mean ± SD | 4.09 ± 2.91 | 3.10 ± 2.10 | 3.35 ± 4.43 | | | Median; min.–max. | 3.20; 0.10–13.60 | 4.30; 0.80–4.80 | 1.20; 1.0–10.0 | | | CD7+ | | | | 0.585 | | Mean ± SD | 74.22 ± 12.60 | 80.0 ± 3.77 | 77.4 ± 4.35 | | | Median; min.–max. | 76.60; 2.80–98.0 | 79.2; 74.60–84.0 | 79.05; 71.10–80.40 | | | CD4+CD7+ | | | | 0.478 | | Mean ± SD | 38.98 ± 11.50 | 40.68 ± 7.40 | 37.22 ± 17.86 | | | Median; min.–max. | 38.60; 9.60–96.50 | 44.80; 31.10–46.80 | 31.75; 22.30–63.10 | | | CD4+CD7− | | | | 0.193 | | Mean ± SD | 9.62 ± 11.53 | 4.52 ± 1.43 | 4.95 ± 3.87 | | | Median; min.–max. | 5.60; 0.50–88.90 | 4.90; 2.20–6.10 | 3.40; 2.30–10.70 | | | CD71+ | | | | 0.091 | | Mean ± SD | 5.70 ± 9.98 | 1.80 ± 0.71 | 15.65 ± 23.69 | | | Median; min.–max. | 3.0; 0.1–71.0 | 1.90; 0.8–2.80 | 4.95; 1.6–51.1 | |
| | B cell surface antigens | | HLA-DR+ | | | | 0.368 | | Mean ± SD | 30.47 ± 10.05 | 28.06 ± 5.81 | 37.22 ± 16.46 | | | Median; min.–max. | 29.2; 2.20–60.20 | 26.4; 20.6–36.0 | 33.6; 21.80–59.90 | | | CD19+ | | | | 0.468 | | Mean ± SD | 11.66 ± 4.81 | 12.74 ± 4.77 | 9.40 ± 3.84 | | | Median; min.–max. | 11.70; 1.0–24.80 | 10.90; 8.90–20.80 | 9.95; 4.90–12.80 | | | HLA-DR+CD19+ | | | | 0.559 | | Mean ± SD | 10.80 ± 4.80 | 12.22 ± 4.70 | 8.20 ± 3.34 | | | Median; min.–max. | 10.70; 0.30–24.70 | 10.40; 8.70–20.10 | 50; 4.60–11.20 | |
| | NKT cells surface antigens | | CD3+CD16+CD56+ | | | | 0.027 | | Mean ± SD | 3.31 ± 3.26 | 1.54 ± 0.78 | 1.92 ± 1.30 | | | Median; min.–max. | 2.20; 0.20–20.50 | 1.20; 0.90–2.80 | 1.95; 0.70–3.10 | |
| | NK cells surface antigens | | CD3−CD16+CD56+ | | | | 0.523 | | Mean ± SD | 12.92 ± 8.06 | 13.56 ± 5.28 | 16.87 ± 1.83 | | | Median; min.–max. | 12.80; 0.10–39.80 | 13.60; 7.30–21.50 | 17.55; 2.20–30.20 | |
|
|
